India Plans Data Protection of Up to 5 Years for Pharma Patents

Law360, New York (December 2, 2003, 12:00 AM EST) -- In a policy reversal, India’s government is expected to propose data protection for a period of three to five years for pharmaceutical inventors, the Economic Times of India reported on Tuesday.

Under the proposed regulatory framework, data protection would be subsumed in the patent period, commencing from date of the first marketing approval for the product in any country. Inventor applicants must furnish all the data called for by the regulator, according to the Economic Times.

India’s Commerce Department is believed to have made the proposal...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.